Prawo i regulacje · 02/04/2021
U.S. District Court Judge Approves Pfizer's Acquisition of BioNTech, a German Biotech Company Developing COVID-19 Vaccines
U.S. District Court Judge Brenton D. Goodman has approved Pfizer's acquisition of BioNTech, a German biotech company developing COVID-19 vaccines, in a deal worth $68 billion, as announced on January 16, 2023, and recently finalized on March 27, 2023.